Palladia Tablets for dogs 10mg (pack of 20)

Category: P

Select Option
Palladia Tablets for dogs 10mg (pack of 20) - € 105.25
QTY:
Palladia Tablets for dogs 50mg (pack of 20) - € 390.22
QTY:

Total Price: €0.00


Vat Rate: 20%

Prescription Required



For the treatment of non-resectable Patnaik grade II (intermediate grade) or III (high grade), recurrent, cutaneous mast cell tumours in dogs. For the treatment of non-resectable Patnaik grade II (intermediate grade) or III (high grade), recurrent, cutaneous mast cell tumours in dogs.

Royal Mail 2nd Class / Parcel Force 48

UK to UK :Normally arrives in 2-4 business days.

UK to Ireland :Normally arrives in 4-6 business days

UK to EU Countries : Normally arrives in 6-10 working days depending on where the parcel is going

 

Please note standered delivery is none trackable , none insured , no responsabily for lose or Damage

 

----------------------------------------------------------------------------------------------------------------

 

Royal Mail First Class / Parcel Force 24

UK to UK :Normally arrives in 1-2 business days.

UK to Ireland 3-4 business days

UK to EU Countries : Normally arrives in 6-10 working days depending on where the parcel is going

 

Please note :Trackable , Royal Mail insured up to £50.

 

--------------------------------------------------------------------------------------------------------

Parcel Force Express AM Guaranteed before Midday.

UK to UK only . UP to 5KG Max Weight

Arrives next day before 12 noon, requires a signature.

 

Parcel Forcel Terms & Conditions apply

 

Important: Parcel Force advise that there are some postcodes where an extended delivery time exists, and may affect the date of delivery or the service is not available.

 

You must be logged in to write review
Category POM-V
Temperature Ambient
MA/VM/EU No: EU/2/09/100/001
Species
  • dog
VMD Link Product Information Database (defra.gov.uk)
NOAH Link https://www.noahcompendium.co.uk/?id=-457830
Dosage For oral use. Tablets can be administered with or without food. The initial recommended dose is 3.25 mg/kg bodyweight, administered every second day (see dosing table for details). The dose given should be based on veterinary assessments conducted weekly for the first six weeks and, thereafter, every six weeks. Duration of treatment depends on the response to treatment. Treatment should continue in the case of stable disease, or partial or complete response, provided that the product is sufficiently well tolerated. In case of tumour progression, treatment is unlikely to be successful and should be reviewed. See dosing table on the following page: Bodyweight (kg) Number of tablets 10 mg (blue) 15 mg (orange) 50 mg (red) 5.0* - 5.3 1 5.4 - 6.9 2 7.0 - 8.4 1 plus 1 8.5 - 10.0 2 10.1 - 11.5 2 plus 1 11.6 - 13.0 1 plus 2 13.1 - 14.6 3 14.7 - 16.1 1 16.2 - 17.6 1 plus 3 17.7 - 19.2 1 plus 1 19.3 - 20.7 1 plus 1 20.8 - 23.0 2 plus 1 23.1 - 26.9 2 plus 1 27.0 - 29.9 3 plus 1 30.0 - 32.3 2 32.4 - 34.6 1 plus 2 34.7 - 36.1 1 plus 2 36.2 - 38.4 2 plus 2 38.5 - 43.0 2 plus 2 43.1 - 47.6 3 47.7 - 49.9 1 plus 3 50.0 - 51.5 1 plus 3 51.6 - 53.8 2 plus 3 53.9 - 58.4 2 plus 3 58.5 - 63.0* 4 * The number of tablets required for dogs below 5.0 kg or above 63 kg bodyweight, should be calculated based on the 3.25 mg/kg dosage regime. Dose adjustment/reduction To manage adverse reactions, the dose may be reduced to 2.75 mg/kg bodyweight or further to 2.25 mg/kg bodyweight administered every second day or treatment can be discontinued for up to two weeks (see Dose Adjustment table on the following page). For oral use. Tablets can be administered with or without food. The initial recommended dose is 3.25 mg/kg bodyweight, administered every second day (see dosing table for details). The dose given should be based on veterinary assessments conducted weekly for the first six weeks and, thereafter, every six weeks. Duration of treatment depends on the response to treatment. Treatment should continue in the case of stable disease, or partial or complete response, provided that the product is sufficiently well tolerated. In case of tumour progression, treatment is unlikely to be successful and should be reviewed. See dosing table on the following page: Bodyweight (kg) Number of tablets 10 mg (blue) 15 mg (orange) 50 mg (red) 5.0* - 5.3 1 5.4 - 6.9 2 7.0 - 8.4 1 plus 1 8.5 - 10.0 2 10.1 - 11.5 2 plus 1 11.6 - 13.0 1 plus 2 13.1 - 14.6 3 14.7 - 16.1 1 16.2 - 17.6 1 plus 3 17.7 - 19.2 1 plus 1 19.3 - 20.7 1 plus 1 20.8 - 23.0 2 plus 1 23.1 - 26.9 2 plus 1 27.0 - 29.9 3 plus 1 30.0 - 32.3 2 32.4 - 34.6 1 plus 2 34.7 - 36.1 1 plus 2 36.2 - 38.4 2 plus 2 38.5 - 43.0 2 plus 2 43.1 - 47.6 3 47.7 - 49.9 1 plus 3 50.0 - 51.5 1 plus 3 51.6 - 53.8 2 plus 3 53.9 - 58.4 2 plus 3 58.5 - 63.0* 4 * The number of tablets required for dogs below 5.0 kg or above 63 kg bodyweight, should be calculated based on the 3.25 mg/kg dosage regime. Dose adjustment/reduction To manage adverse reactions, the dose may be reduced to 2.75 mg/kg bodyweight or further to 2.25 mg/kg bodyweight administered every second day or treatment can be discontinued for up to two weeks (see Dose Adjustment table on the following page).
Withdrawals